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Znf179 is a member of the RING ﬁnger protein family. During embryogenesis, Znf179 is expressed in a restricted manner in the
brain, suggesting a potential role in nervous system development. In this report, we show that the expression of Znf179 is
upregulatedduringP19cellneuronaldifferentiation.InhibitionofZnf179expressionbyRNAinterferencesigniﬁcantlyattenuated
neuronal differentiation of P19 cells and a primary culture of cerebellar granule cells. Using a microarray approach and
subsequent functional annotation analysis, we identiﬁed differentially expressed genes in Znf179-knockdown cells and found
that several genes are involved in development, cellular growth, and cell cycle control. Flow cytometric analyses revealed that
the population of G0/G1 cells decreased in Znf179-knockdown cells. In agreement with the ﬂow cytometric data, the number of
BrdU-incorporated cells signiﬁcantly increased in Znf179-knockdown cells. Moreover, in Znf179-knockdown cells, p35, a
neuronal-speciﬁc Cdk5 activator that is known to activate Cdk5 and may affect the cell cycle, and p27, a cell cycle inhibitor, also
decreased. Collectively, these results show that induction of the Znf179 gene may be associated with p35 expression and p27
protein accumulation, which lead to cell cycle arrest in the G0/G1 phase, and is critical for neuronal differentiation of P19 cells.
Cell Death and Differentiation (2011) 18, 1791–1804; doi:10.1038/cdd.2011.52; published online 13 May 2011
Neurogenesisisatightlyregulatedprocessthatiscoordinated
with cell cycle regulation and cell fate determination.
1,2 To
initiate terminal differentiation, neural progenitors must exit
the cell cycle, suggesting the existence of crosstalk between
the signal pathways that control these two mechanisms. In
eukaryotes, cell cycle progression is positively regulated by
complexes of cyclin-dependent kinases (CDKs) and asso-
ciated cyclins and is negatively regulated by cyclin-dependent
kinase inhibitors (CKIs). Mammalian CKIs are divided into two
families: the INK4 family, including p15, p16, p18, and p19;
and the Cip/Kip family, including p21, p27, and p57.
3 Among
CKIs, p27 is of particular importance for neurogenesis. For
instance, p27 is expressed in the developing brain and was
implicated in promoting cell cycle arrest of neural progeni-
tors.
4,5 In addition to animal experiments, the role of p27 in
neuronal differentiation was also observed in several cell
modelssuchasP19embryonalcarcinomacells.
6p27bindsto
both cyclin D-Cdk4,6 and cyclin E-Cdk2 complexes to inhibit
kinase activity, which leads to the arrest of the cell cycle in the
G1 phase.
7,8 Recent studies revealed that p27 is involved in
cell cycle withdrawal and also neuronal migration.
9 In one
study, Cdk5 and its activator, p35, were found to phosphor-
ylate and stabilize p27. Unlike other CDKs that have central
roles in cell cycle progression, Cdk5 is activated in post-
mitotic neurons by non-cyclin proteins such as p35 and is
known to be important in nervous system development.
10
Znf179, a gene withunknown function, belongs to the RING
ﬁnger protein family, which is characterized by a zinc-binding
domain that serves as a protein-binding interface. RING
ﬁnger proteins are implicated in the function of diverse cell-
ular processes such as gene transcription, cell growth,
cellular differentiation, and apoptosis, as well as in abnormal
cellular behaviors such as oncogenesis.
11 Recent studies
indicated that many RING ﬁnger proteins act as E3 ubiquitin
ligases and are associated with a ubiquitin proteasome
pathway.
12 RING ﬁnger proteins such as Mdm2, Mib, and
G2E3 perform essential roles in embryonic and postnatal
development.
13–15 The expression of the Znf179 gene is
restricted to the brain and is regulated during brain develop-
ment.
16 In the previous studies, Inoue et al.
17 also reported
that Znf179 is expressed in the retinoic acid (RA)-induced
neuronal differentiated P19 cells. These ﬁndings suggest that
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www.nature.com/cddZnf179 may have a role in brain development and neuronal
differentiation. However, there is no further study that has
conﬁrmed this hypothesis. Moreover, microarray analyses
revealed that Znf179 is signiﬁcantly downregulated in neuro-
degenerative diseases such as Huntington’s disease (HD)
and amyotrophic lateral sclerosis, implying that Znf179 might
be associated with neurodegenerative diseases.
18,19
In this study, we observed dramatic increases in Znf179
messenger (m)RNA and protein during P19 cell neuronal
differentiation. Suppressing Znf179 induction impaired P19
cell neuronal differentiation. We further explored the under-
lying mechanism and found that Znf179 knockdown resulted
in decreased expressions of p35 and p27 and interfered with
cell cycle withdrawal and neuronal differentiation in P19 cells.
To the best of our knowledge, this is the ﬁrst study to provide
evidence that Znf179 functions in neuronal differentiation.
Results
Znf179 protein expression is restricted to the brain
and particularly to neurons. Although the Znf179 gene
was cloned 410 years ago, its function has not yet been
elucidated.
17 In this study, we generated polyclonal
antibodies against Znf179 and used those antibodies to
examine Znf179 protein expressions in various tissues.
Antibody validation was performed, and the result is shown
in Supplementary Figure S1. Among the examined tissues, a
high level of Znf179 protein was observed in the brain
(Figure 1a). We further compared expressions of the Znf179
protein in different brain regions and found that Znf179 was
equally expressed in all selected regions, including the
cerebral cortex, striatum, hippocampus, and cerebellum
(Figure 1b), suggesting that Znf179 may have a general
role in the brain. Using in situ hybridization, we also detected
transcripts of Znf179 in the developing brain. As shown in
Figure 2, Znf179 mRNA was detected in many brain areas,
including cerebral cortex, hippocampus, and cerebellum.
These data are consistent with a previous study
16 and
with the result of Allen Brain Atlas gene expression data-
base (Image Series: 393241). Moreover, we found that the
expression of Znf179 increased gradually during cere-
bellum development, suggesting a potential role of Znf179
in nervous system development. To further elucidate the
cellular identity of Znf179-expressing cells, primary cultures
of mouse cerebellar cells were immunostained with Znf179
and microtubule-associated protein 2 (MAP2) (a neuronal
marker) or glial ﬁbrillary acidic protein (GFAP) (a glial
marker). As shown in Figure 1c, Znf179 was highly expres-
sed in MAP2-positive cells and slightly expressed in GFAP-
positive cells. Our result is consistent with the previous study
by Orimo et al.
16, which showed that Znf179 was detected in
both neuron and glial cells.
Znf179 expression is upregulated during P19 cell
neuronal differentiation. To study the function of the
Znf179 gene, P19 embryonal carcinoma cells, a pluripotent
cell line that can be induced by RA to differentiate into neurons,
were used as the model.
20 Using MAP2 immunoﬂuorescent
staining, we examined the neuronal differentiation of P19 cells.
As shown in Figure 3a, monolayer-cultured P19 cells
were undifferentiated and did not express the neuronal
marker, MAP2. In contrast, neuronally differentiated P19 cells
showed strong positive staining with the anti-MAP2 antibody
(Figure 3b). During RA-induced P19 cell neuronal differen-
tiation, the quantitative RT-PCR analysis showed that Znf179
messenger (m)RNA was dramatically increased after 4 days of
aggregation in the presence of RA (Figure 3c). After plating, the
expression of Znf179 further increased and was maintained at a
high level. We also found that P19 cell aggregation in the
absence of RA did not induce the expression of Znf179,
indicating that RA was required for Znf179 induction during P19
cell neuronal differentiation. We detected the protein expression
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Figure 1 Expression patterns of the Znf179 protein. (a and b) Western blot
analysis of Znf179 in various adult (8-week-old) mouse tissues (a) and brain areas
(b). (c) Primary cultured cerebellar cells (6 days in vitro) were double-
immunostained with Znf179 and either MAP2 or GFAP, and counterstained with
DAPI. Arrows indicate the MAP2/Znf179 or GFAP/Znf179 double labeled cells.
Scale bar, 10mm
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Cell Death and Differentiationof Znf179 and found that the pattern of Znf179 protein
expression was similar to that of Znf179 mRNA expression
(Figure 3d). In the western blot analysis, the neuronal markers,
growth-associated protein 43 (GAP-43) and bIII-tubulin, were
also detected and highly expressed in differentiated P19 cells,
indicating that the cells had differentiated into neurons.
Consistent with the ﬁndings reported by Inoue,
17 our results
revealed that Znf179 is elevated during the differentiation of
P19 cells into neurons and provided the precise time course of
Znf179 gene expression. The results show that Znf179 may be
required for neuronal differentiation.
Inhibition of Znf179 elevation by RNA interference
leads to attenuated neuronal differentiation of P19 and
cerebellar granule cells. Given that Znf179 expression was
dramatically induced during RA-induced P19 cell neuronal
differentiation, we speculated that Znf179 may have a role in
neuronal differentiation. In order to elucidate this possibility,
we used lentiviral small hairpin (sh)RNA to knockdown
Znf179 and examined the effect of Znf179 knockdown on
P19 cell neuronal differentiation. Infection efﬁciency was
analyzed by ﬂow cytometry. More than 90% of the cells were
infected (Supplementary Figure S2). As shown in Figure 4a,
two Znf179 shRNA viruses (sh_2 and sh_3), which target
different regions of the Znf179 transcript, signiﬁcantly
reduced expression of the Znf179 protein after 4 days of
aggregation in the presence of RA. In contrast, the negative
control, the lentiviral shRNA that targets the luciferase gene,
had no effect on Znf179 expression. After plating, we
examined the neuronal differentiation of P19 cells by
P3 P3
P7 P7
P14 P14
P14 P14
Figure 2 In situ hybridization of Znf179 in developing brain. Sagittal sections of
mouse brain at the indicated stages were hybridized with the mouse Znf179
antisense (a–c) or sense probe (d). Scale bar, 200mm
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Figure 3 Induced expression of Znf179during P19 cell neuronaldifferentiation.
(a and b) Monolayer undifferentiated (a) and neuronally differentiated P19 cells (b),
which had aggregated in the presence of 1mM RA for 4 days followed by plating on
culture dishes for 6 days, were immunostained with an anti-MAP2 antibody and
counterstained with DAPI. (c) qRT-PCR analysis of Znf179 mRNA levels,
normalized to b-actin, from different days of P19 cell neuronal differentiation.
(d) Western blot analysis of protein expressions of Znf179 and the neuronal
markers, GAP-43 and bIII-tubulin, from different durations of P19 cell neuronal
differentiation. Values represent the mean of at least three independent
experiments±S.E.M. Statistical analysis was performed using one-way ANOVA
with appropriate post hoc tests: *Po0.05 versus control monolayer P19 cells (M).
Agg, aggregation; Con, vehicle control; D, day. Scale bar, 10mm
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Cell Death and Differentiationimmunoﬂuorescent staining of the neuronal marker, MAP2.
As shown in Figure 4b, high percentage of MAP2-positive
cells were shown in control (non-infected and control virus-
infected) cultures, whereas the number of MAP2-positive
cells was signiﬁcantly reduced in Znf179 shRNA virus-
infected cells. Quantiﬁcation of results showed that both
the total number and the percentage of MAP2-positive cells
were markedly reduced (Figures 4c and d). MAP2 protein
expression was also detected by a western blot analysis,
and similar results were observed (Figure 4e). In addition to
MAP2-positive cells, the total cell number was also reduced
in Znf179 shRNA virus-infected cells (Figure 4c). An MTT
assay was performed to evaluate the number of attached
cells after 4h and 6 days of plating, which may reﬂect the
proliferation or survival rate. As shown in Supplementary
Figure S3, in control (non-infected and control virus-infected)
cultures, the number of attached cells did not change
between 4h and 6 days of plating, indicating that the
attached cells did not undergo proliferation. This is because
proliferative, undifferentiated cells died in the serum-free
media after plating. In contrast, after 6 days of plating, the
amount of cells signiﬁcantly decreased compared with that
with 4h of plating in Znf179 shRNA virus-infected cells.
These results revealed that inhibition of Znf179 elevation
could attenuate RA-induced P19 cell neuronal differentiation,
which may have resulted from poor survival of cells during
neuronal differentiation. To deﬁne whether early steps of
the differentiation process were equally affected in culture,
we detected the early neuronal marker, bIII-tubulin. As
shown in Figure 4a, two Znf179 shRNA viruses (sh_2 and
sh_3) reduced the expression of bIII-tubulin after 4 days of
aggregation in the presence of RA, indicating that the cell
fate was affected in the early stages of differentiation. We
further detected the expression of neurogenin2 and neuroD1.
Our results showed that the protein and mRNA expressions
of neurogenin2 and neuroD1 did not change by knockdown
of Znf179 (data not shown), indicating that the functional
mechanisms of Znf179 on neuronal differentiation are diffe-
rent from neurogenein2 or neuroD1, or Znf179 functions
downstream to neurogenein2 or neuroD1.
In addition to P19 cells, we also examined the effect of
Znf179 knockdown on primary cultured cerebellar granule
cells. In a similar manner to P19 cells, knockdown of Znf179
expression led to attenuated cerebellar granule neuronal
differentiation (Figures 5aand b).Immunoﬂuorescentstaining
of the neuronal marker, MAP2, revealed that both the total
number and the percentage of MAP2-positive cells were
reduced in Znf179 shRNA virus-infected cerebellar granule
cells (Figures 5c and d). As shown in Figure 5c, the total cell
number also decreased in Znf179 shRNA virus-infected cells,
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Figure4 Lentivirus-mediatedshRNAinterferencetargetingZnf179inhibitstheneuronaldifferentiationofP19cells.P19cellswereinfectedwithsiZnf179(sh_2orsh_3)or
control (sh_Neg, against luciferase) viruses before 2 days of cell aggregation. (a) Western blot analysis of Znf179 and bIII-tubulin protein expressions in non-infected, control
virus- (sh-Neg), or si-Znf179 virus (sh_2 and sh_3)-infected P19 cells, which were aggregated in the presence of 1mM RA for 4 days. (b) Immunostaining of neuronally
differentiated P19 cells, which were aggregated in the presence of RA for 4 days and then plated in culture dishes for another 6 days, with an anti-MAP2 antibody. (c and d)
The density and percentage of MAP2-positive cells were determined in differentiated P19 cells. MAP2-positive and -negative cells were counted at  200 magniﬁcation in at
least10ﬁeldsofview,andatleast500cellswerecountedintotal.Thecellswithpycnoticnucleiwerenotcounted.(e)WesternblotanalysisofMAP2proteinexpressioninnon-
infected, control virus- (sh-Neg), or si-Znf179 virus (sh_2 and sh_3)-infected P19 cells, which were aggregated in the presence of RA for 4 days and then plated in culture
dishes for another 6 days. Values represent the mean of at least three independent experiments±S.E.M. Statistical analysis was performed using one-way ANOVA with
appropriate post hoc tests: *Po0.05 versus the non-infected group. Scale bar, 20mm
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Cell Death and Differentiationindicating that cell viability was affected during the process of
neuronal differentiation. To examine whether Znf179 knock-
down also had an effect on glial differentiation, the glial
marker, GFAP, was used for immunoﬂuorescent staining.
As shown in Figure 6, knockdown of Znf179 also led to
attenuation of glial differentiation in primary cerebellar cul-
tures. These results showed that Znf179 has a functional role
in both neuronal and glial differentiation. The effect was seen
in the cell line model, and also in the primary culture system.
Identiﬁcation and annotation analysis of differentially
expressed genes with Znf179 knockdown. To dissect the
neuronal differentiation mechanisms of Znf179, we used a
microarray to compare the global gene expression proﬁles
between Znf179-knockdown and control cells, both of
which were aggregated for 4 days in the presence of RA.
Microarray results showed that compared with control virus-
infected cells, 52 genes were found to be upregulated
and 110 genes were found to be downregulated by Z1.5-fold
in both Znf179 shRNA virus (sh_2 and sh_3)-infected
cells (Supplementary Table S2). Two upregulated and four
downregulated genes were randomly chosen, and their
expressions were measured by a quantitative RT-PCR
analysis. The results are consistent with the microarray
data (Table 1). We used the 162 (52 upregulated and 110
downregulated) genes to perform a functional annotation
analysis using the ingenuity pathway analysis (IPA). As
shown in Figure 7a, the ﬁve highest-ranking processes in the
category of ‘physiological system development and func-
tions’ were associated with development, including organ
development, embryonic development, tissue development,
and nervous system development. This result further sup-
ports the role of Znf179 in neuronal development. In addition,
cell growth, proliferation, and the cell cycle were identiﬁed
to be the most signiﬁcant molecular and cellular functions
(Figure 7b). It is known that withdrawal from the cell cycle
is a prerequisite for terminal differentiation. Thus, we
were interested in determining whether Znf179 affects cell
cycle progression, subsequently resulting in neuronal
differentiation.
Effect of Znf179 knockdown on the cell cycle proﬁle
and cell cycle regulatory proteins. To examine the role of
Znf179 in the cell cycle during neuronal differentiation, P19
cells were infected with negative control and Znf179 shRNA
viruses. After 4 days of aggregation in the presence of RA,
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Figure 5 Lentivirus-mediated shRNA interference targeting Znf179 inhibits the neuronal differentiation of cerebellar granule cells. Cerebellar granule cells were infected
with siZnf179 (sh_2 or sh_3) or control (sh_Neg, against luciferase) viruses at 0 days in vitro. Western blot analysis of Znf179 protein expression (a) and immunostaining
of MAP2 (b) were performed at 2 and 6 days, respectively. (c and d) The density and percentage of MAP2-positive cells were determined in cerebellar granule cells.
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counted. Values represent the mean of at least three independent experiments±S.E.M. Statistical analysis was performed using one-way ANOVA with appropriate post hoc
tests: *Po0.05 versus the non-infected group. Scale bar, 20mm
Znf179 regulates neuronal differentiation
P-C Pao et al
1795
Cell Death and Differentiationﬂow cytometry was performed to investigate whether Znf179
knockdown had affected cell cycle withdrawal in P19
cells. As expected, G0/G1-phase cells in RA-treated P19
cells had increased compared with non-treated cells (Figures
8a and b), in agreement with RA-induced cell cycle arrest
and neuronal differentiation in P19 cells. However, Znf179
knockdown was able to abolish the increase in G0/G1-phase
cells caused by RA treatment, indicating a failure to establish
G0/G1 arrest. BrdU incorporation and phospho-histone H3
expression were used to assess cell proliferation. The results
were similar to those in ﬂow cytometric experiments. As
shown in Figures 8c and d and 9c, both the percentage of
Non-infected
sh_2
3500 450 18
16
14
12
10
8
6
4
2
0
400
350
300
250
G
F
A
P
-
p
o
s
t
i
v
e
 
c
e
l
l
 
(
p
e
r
 
m
m
2
)
G
F
A
P
-
p
o
s
t
i
v
e
 
c
e
l
l
 
(
%
)
200
150
100
50
0
3000
*
*
*
*
2500
2000
1500
t
o
t
a
l
 
c
e
l
l
 
n
u
m
b
e
r
/
m
m
2
1000
500
0
Virus:
-
sh_Neg
sh_2
sh_3 -
sh_Neg
sh_2
sh_3 -
sh_Neg
sh_2
sh_3
sh_3
sh_Neg
Figure 6 Lentivirus-mediated shRNA interference targeting Znf179 inhibits the glial differentiation of cerebellar granule cells. (a) Cerebellar granule cells were infected
with siZnf179 (sh_2 or sh_3) or control (sh_Neg, against luciferase) viruses at 0 days in vitro and were immunostained with an anti-GFAP antibody at 6 days in vitro.
(b–d) The density and percentage of GFAP-positive cells was determined in cerebellar granule cells. GFAP-positive cells were counted at  400 magniﬁcation in at least 10
ﬁelds of view, and at least 500 cells were counted. The cells with pycnotic nuclei were not counted. Values represent the mean of at least three independent
experiments±S.E.M. Statistical analysis was performed using one-way ANOVA with appropriate post hoc tests: *Po0.05 versus the non-infected group. Scale bar, 20mm
Table 1 Quantitative RT-PCR analysis to verify differentially expressed genes
sh_2 versus sh_Neg sh_3 versus sh_Neg
Accession number Gene symbol Microarray qRT-PCR Microarray qRT-PCR
NM_021415 Cacna1h 0.60 0.40 0.65 0.39
NM_009871 Cdk5r1 0.67 0.50 0.58 0.60
NM_009708 Rnd2 0.62 0.65 0.42 0.33
NM_080853 Slc17a6 0.45 0.38 0.23 0.14
NM_145367 Txndc5 1.63 1.40 1.51 1.73
NM_009498 Vamp3 1.50 1.87 1.73 1.63
A number of genes that were reported to be differentially expressed by the microarray analysis were measured using the quantitative RT-PCR
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Cell Death and DifferentiationBrdU-positive cells and the expression of phospho-histone
H3 increased in Znf179-knockdown cells. These results
show that Znf179 has a role in inhibiting cell cycle prog-
ression, particularly in blocking cells at the G0/G1-phase,
and promotes neuronal differentiation. Among the differen-
tially expressed genes with Znf179 knockdown, cyclin D3
(Ccdn3) and p35 (Cdk5r1) are closely linked to cell cycle
regulation. Ccdn3 is known to activate Cdk4 and Cdk6, and
thereby stimulate G1 progression.
21 On the other hand, p35
is known to activate Cdk5 to phosphorylate and stabilize
p27, thereby promoting cell cycle arrest.
9 Our microarray
results showed that Ccdn3 was upregulated and p35 was
downregulated in Znf179-knockdown cells (Supplementary
Table 2). This result is consistent with the ﬂow cytometric
data showing that Znf179 knockdown reduced the G0/G1
fraction (Figures 8a and b).
We further examined the expression patterns of Ccdn3
and p35 mRNAs, and found that the level of Ccdn3 did not
signiﬁcantly change during P19 cell neuronal differentiation
(Figure 9a). In contrast, p35 expression, similar to Znf179
expression, dramatically increased during P19 cell neuronal
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Figure 8 Znf179 knockdown affects the cell cycle proﬁle in P19 cells. P19 cells were infected with a control (sh_Neg, against luciferase) or siZnf179 (sh_2) virus before 2
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Figure 7 IPA of functional categories for differentially expressed genes in
Znf179-knockdown cells. The functionsof 162 genes with 4 or o1.5-fold changes
in expression by Znf179-knockdown cells were categorized using IPA. The top ﬁve
physiological system development and function categories (a) and molecular and
cellular function categories (b) are shown. Signiﬁcance refers to the –log(P-value),
which was obtained by the Ingenuity program using a right-tailed Fisher’s exact test
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Cell Death and Differentiationdifferentiation (Figure 9a). This suggests that p35 has a more
important role than Ccdn3 in P19 cell neuronal differentiation.
To investigate whether the induction of p35 is associated with
p27 accumulation, we detected the protein expressions of
p35, Cdk5, p27, and Ser10-phosphorylated p27 during P19
cell neuronal differentiation. During the process, as shown in
Figure 9b,while theprotein levelofCdk5 remainedessentially
the same, protein levels of p35, p27, and Ser10-phosphory-
lated p27 dramatically increased. In addition to P19 cells, we
also detected protein expressions of Znf179, p35, p27, and
Ser10-phosphorylated p27 during cerebellar granule cell
neuronal differentiation and found similar results (Supple-
mentary Figure S4). Our data showed strong correlations of
temporal expression patterns among Znf179, p35, and p27
during P19 cell neuronal differentiation. These all support the
hypothesis that Znf179 regulates p35 and p27 expressions
and results in cell cycle arrest during the neuronal differ-
entiation of P19 cells. To further investigate this possibility,
we examined the protein expressions of these genes in
Znf179-knockdown P19 cells. As shown in Figure 9c, Znf179
knockdown decreased expressions of the p35, p27, and
Ser10 phosphorylated p27 proteins. We further analyzed
mRNA expression by a quantitative RT-PCR. Similar to the
microarray data, the quantitative RT-PCR analysis revealed
a signiﬁcant decrease in p35 mRNA in Znf179-knockdown
P19 cells (Figure 9d). In contrast, p27 mRNA did not change
(Figure 9d). These results reveal that Znf179 is required for
proper neuronal differentiation and suggest p35 and p27 as
possible mediators.
Effect of p35 knockdown is similar but not identical to
that of Znf179 knockdown. To examine the possibility that
p35 mediates Znf179’s function in neuronal differentiation,
we used lentiviral shRNA to knock down p35 and examined
the effect of p35 knockdown on P19 cell neuronal differen-
tiation. As shown in Figure 10a, a p35 shRNA virus (sh_4)
signiﬁcantly reduced expression of the p35 protein after
4 days of aggregation in the presence of RA. In contrast, the
negative control, the lentiviral shRNA that targets the
luciferase gene, had no effect on p35 expression. Similar to
Znf179, knockdown of p35 increased BrdU incorporation
(Figures 10b and c) and attenuated neuronal differentiation
(Figures 10d–f). However, the protein expression of p27 did
not change (Figure 10a). We also examined whether p35
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Cell Death and Differentiationre-expression was sufﬁcient to rescue the differentiation
inhibition when Znf179 was silenced. Our results showed that
the effect of Znf179 knockdown on P19 cell neuronal
differentiation was partially rescued by p35 re-expression
(Figure 11 and Supplementary Figure S5). These results
show that although p35 is required for P19 cell neuronal
differentiation, the effect of p35 was not associated with p27
accumulation, and other mechanisms may be also involved
in Znf179’s function.
Discussion
Neuronal differentiation is essential for the formation of the
mammalian nervous system. It is a complex event that is
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Cell Death and Differentiationcoordinated with cell cycle regulation and cell fate determina-
tion. The process of neuronal differentiation is regulated by
various intrinsic factors and extrinsic signals and is still under
investigation. In this study, we demonstrate that Znf179 is a
novel cell-intrinsic factor that is critical for neuronal differ-
entiationinbothP19cellsandtheprimarycultureofcerebellar
granule cells. Our results show that Znf179 functions up-
stream of cell cycle regulatory genes to promote cell cycle exit
and neuronal differentiation.
In this study, we generated polyclonal antibodies against
Znf179 and used these antibodies to examine Znf179
protein expressions in various tissues (Figure 1). Flag- and
HA-tagged mouse Znf179 proteins were expressed in 293T
cells and detected by western blotting with anti-Flag, anti-HA,
or anti-Znf179 antibodies (Supplementary Figure S1). The
immunoblottingexperimentsshowedabandofaround72kDa
in size corresponding to the Flag- or HA-tagged Znf179
protein,whilethesizeofendogenousmouseZnf179proteinin
brain tissue and P19 cells was smaller (Figures 1, 3, 4, and 9).
Two reasons may explain this difference. First, the over-
expressed mouse Znf179 proteins contain an additional
HA- or Flag-tag, which result in a molecular-weight increase.
A second possible reason for the difference in size of the
endogenous and overexpressed mouse Znf179 proteins may
be different transcripts that are generated in mouse brain and
Znf179 expression construct-transfected cells. The mouse
Znf179 gene contains 15 exons (Entrez gene ID: 22671).
Compared with the human and rat Znf179 genes, there is an
additional exon (exon 3), which contains 69 nucleotides in the
coding sequence (Supplementary Figure S6A) of the mouse
Znf179 gene. In fact, a Znf179 transcript lacking exon 3 was
also reported in a mouse cerebellum complementary (c)DNA
library (GenBank acc. no. AK131651). Our result also rev-
ealed there are two alternative Znf179 transcripts (with or
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Cell Death and Differentiationwithout exon 3) in the mouse cortex but not in the rat cortex or
human brain (Supplementary Figure S6B). Therefore, it is
possible that the endogenous Znf179 protein we detected in
the mouse brain and P19 cell lysate was translated from the
transcript lacking exon 3, resulting in a smaller-sized protein
than that of the Flag- or HA-tagged Znf179 proteins, which
were translated from the transcript with exon 3. Moreover, as
the shRNAs against Znf179 reduce the expression of two
bands in primary cells (Figure 5a), we cannot rule out the
possibility of the presence of different Znf179 isoforms in
primary cultured cerebellar granule cells.
Znf179is a RING ﬁngerprotein with a characteristic C3HC4
motif located in the N-terminus. The expression of the Znf179
gene is restricted to the brain and is regulated during brain
development.
16 However, its function has not yet been
elucidated. The human Znf179 gene is located on chromo-
some 17p11.2, which is one of the most recombination-prone
regions of the genome. In fact, the locus of the human Znf179
gene is present in the Smith–Magenis syndrome (SMS)
commondeletionregion.
22Therefore,Znf179wasconsidered
to be one of the candidate genes for SMS.
16 SMS is a com-
plex neuropediatric–neurobehavioral syndrome. Patients are
characterized by moderate mental retardation and multiple
congenital anomalies, including mild craniofacial and skeletal
abnormalities, behavioral abnormalities, sleep disturbances,
a short stature, and cardiac and renal malformations.
23
Although RAI1, another gene located at 17p11.2, is regarded
as the primary gene responsible for most features of
SMS, other genes in the 17p11.2 region still contribute to
the variability and severity of the phenotype of SMS.
24 In
this study, we observed that the Znf179 gene was markedly
induced during P19 cell neuronal differentiation (Figure 3).
We further showed that Znf179 knockdown signiﬁcantly
attenuated neuronal differentiation of P19 cells and the
primary culture of cerebellar granule cells, suggesting that
Znf179participates in neuronal differentiation and may have a
role in SMS.
Using a microarray approach and subsequent functional
annotation analysis, we identiﬁed differentially expressed
genes in Znf179-knockdown cells and found that several
genes were involved in cell proliferation and cell cycle control
(Figure 7b). Furthermore, a ﬂow cytometric study revealed
that Znf179 knockdown abolished the increase in G0/G1-
phase cells caused by RA treatment, suggesting that Znf179
might inhibit cell cycle progression, resulting in neuronal
differentiation. Among differentially expressed cell cycle
regulatory genes, p35 was downregulated in Znf179-knock-
down cells, and the expression pattern of p35 during P19
cell neuronal differentiation was similar to that of Znf179
(Figures 9a and b). p35 is a neuronal-speciﬁc Cdk5 activator.
Expression of p35 and activation of Cdk5 in post-mitotic
neurons are known to be important for nervous system
development.
10 We therefore speculated that p35 may
function downstream of Znf179 to regulate neuronal differ-
entiation. p35 is transcriptionally regulated by various path-
ways and transcription factors such as the ERK pathway and
heat-shock factor 2, which are also important for neuronal
differentiation.
25–27 The mechanism by which Znf179 reg-
ulates p35 expression is not clear and needs further
investigation. A previous study using a microarray analysis
showed that Znf179 was signiﬁcantly downregulated in the
brain of HD transgenic mice.
18 Interestingly, the expression of
p35 also decreased in that animal model. Furthermore, p35/
Cdk5 was found to suppress the formation of mutant
Huntingtin aggregates, a major pathological feature of HD,
in primary cultured neurons.
28 Taken together, these observa-
tions support our speculation that p35 may function downstream
of Znf17, and Znf179 may be associated with HD.
p27, a CKI of the Cip/Kip family, which is involved in
arresting cell cycle progression, was found to be indispen-
sable for neuronal differentiation of embryonal carcinoma
cells and to have a key role in cortical development.
6,29 In that
work,Sasakietal.
6foundthattheexpressionofp27increased
with P19 cell aggregation in the presence of RA, and inhibition
of p27 expression by antisense p27 oligonucleotides resulted
inblockadeofneuronaldifferentiation.Inadditiontoregulating
the cell cycle, p27 was further reported to promote neuronal
differentiation of cortical progenitors by stabilizing the
proneural protein, neurogenin 2.
29 These all suggest that
p27 is a possible mediator of Znf179’s effect on P19 cell
neuronal differentiation. p27 was shown to be phosphorylated
by p35/Cdk5, which resulted in increasing its protein stability.
9
Moreover, the phosphorylation of p27 also promotes its
translocation to the cytoplasm, contributing to unrelated cell
cycle functions such as cell migration.
9,30 In this study, we
observed that in agreement with the decrease in p35
expression, the protein level of p27 and phosphorylated p27
were diminished in Znf179-knockdown cells (Figure 9c).
However, the p27 and phosphorylated p27 protein expression
did not change after knockdown of p35 (Figure 10a),
suggesting thatthe effect of Znf179on p27protein expression
is not mediated by the p35/Cdk5 pathway. In addition to p35/
cdk5, the S-phase kinase-associated protein (Skp)2 was
found to be required for the ubiquitin-mediated degradation of
p27, and destruction of Skp2 is essential for proper terminal
differentiation of neuronal precursors.
31,32 In LAN-5 neuro-
blastoma cells, RA treatment was also found to reduce the
rate of ubiquitin/proteasome-mediated degradation of the p27
protein and induce neuronal differentiation.
33 The possible
mechanisms involved in p27 protein regulation by Znf179 will
be further investigated.
In our result, inhibition of Znf179 elevation leads to
decrease the number of total and MAP2-positive cells
(Figures 4c and 5c). The result revealed that inhibition of
Znf179 elevation can attenuate RA-induced P19 cell neuronal
differentiation, which may have resulted from poor survival of
cells during neuronal differentiation. The possible mechanism
maybeactivationofE2F1,whichisknowntoinducecelldeath
during P19 and cerebellar granule cell differentiation.
34,35 In
our results, Znf179 knockdown led to decreases in p35 and
p27 expressions. p27 is a CKI. The decrease in p27
expression may have resulted in E2F1 activation. Another
recent study also revealed that p35/Cdk5 binds to E2F1 and
inhibits E2F1 activity.
36 We further analyzed microarray data
and found that many E2F1-regulated genes, such as Ccdn3,
calregulin, cellular RA-binding protein II, Mcm3, and Rad54l,
were upregulated by Znf179 knockdown (Supplementary
Table S2). These all imply that E2F1 activation may be the
cause of poor survival of Znf179-knockdown cells during
neuronal differentiation.
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Cell Death and DifferentiationIt is known that withdrawal from the cell cycle is a
prerequisite for terminal differentiation. Recent studies sug-
gested the existence of crosstalk between the signal path-
ways that control these two mechanisms.
1,2 In this study, we
observed that Znf179 regulated cell cycle exit and was critical
for neuronal differentiation. Further studies need to examine
whether Znf179 also participates in cell fate determination.
However, the functional annotation analysis revealed that
several genes closely associated with nervous system
development and function were differentially expressed
in Znf179-knockdown cells (Figure 7a). For instance, the
expressionsofGAP-43,MAPT,neurexin2(NRXN2),NRXN3,
glycoprotein M6A, and so on, which are all neuronal proteins
and involved in neuronal differentiation, maturation, and neu-
ronal cell functions, decreased upon knockdown of Znf179
(Supplementary Table S2).
37–39 These results show that
Znf179 may also regulate neuronal cell fate determination.
In conclusion, we demonstrate that Znf179, a brain-speciﬁc
RING ﬁnger protein, is induced during P19 cell neuronal
differentiation and is predominantly expressed in neurons.
We also reveal the cellular function of Znf179 in neuronal
differentiation for the ﬁrst time and further demonstrate that
Znf179 possibly promotes neuronal differentiation through
inhibiting cell cycle progression. Finally, p35 expression and
p27 protein accumulation, which are important for neuronal
differentiation, are associated with the expression of Znf179,
suggesting the possible molecular mechanisms by which
Znf179 exerts its function.
Subjects and Methods
Animals. Male C57BL/6 J (B6) mice (8 weeks old) used in this study were
treated in accordance with guidelines of the University Committee on the Care and
Use of Experimental Animals of National Cheng Kung University (Tainan, Taiwan).
They were housedin an air-conditioned vivarium with free accessto food and water
and a 12/12-h light/dark cycle.
Antibodies. The following antibodies were used for the western blot and
immunoﬂuorescence analyses. Antibodies against MAP2, and b-actin were
purchased from Sigma-Aldrich (St. Louis, MO, USA); those against Cdk5, p35,
p27, phospho-Ser 10 p27, and phospho-Ser 10 histone H3 were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA); that against GAP-43 was
purchased from AbD Serotec (Raleigh, NC, USA); and those against bIII-tubulin
and GFAP were purchased from Promega (Madison, WI, USA) and Zymed
Laboratories (San Francisco, CA, USA), respectively. The polyclonal Znf179
antibodies were generated against a synthetic peptide (CEKEEDERVQ
GDREPLLQEE) corresponding to C terminal amino acids 634B654 of mouse
Znf179.
In situ hybridization. The brains of P3, P7, and P14 mice were ﬁxed by
transcardialperfusionwith4%paraformaldehydein0.lMphosphatebuffer,followed
byimmersion2daysat41C.Thespecimenswerethendehydratedin30%sucrose,
embedded in OCT, and cryosectioned into 10-mm sections. The sections were then
mounted onto poly-L-lysine-coated glass slides and treated with proteinase K
(0.5mg/ml; Sigma-Aldrich) and 0.25% acetic anhydride (Sigma-Aldrich). After
acetylation, the sections were dehydrated by a graded series of ethanol and then
stored at  801C. To generate Znf179 probes for hybridization, a 821-bp Znf179
cDNA fragment was generated by PCR using IMAGE clone 4506141 (GeneBank
entry BC037118) as template with the forward primer 50-GAGCCGC
TGTCAAGGGTA-30 and the reverse primer 50-CCCAGCTCAGCCAGTGTT-30.
The cDNA fragment was subsequently inserted into the pGEM-T Easy vector. The
radiolabeled (
35S) sense and antisense cRNA probes were synthesized using an
in vitro transcription kit from Promega, and were then puriﬁed with Sephadex G-50
column (Amersham Biosciences, Piscataway, NJ, USA). Dehydrated sections were
hybridized with probes (10
4c.p.m./ml) at 601C for 16h. After hybridization, the
sections were washed, dehydrated, and exposed to X-ray ﬁlm.
Primary cultures of mouse cerebellar granule cells. Cerebellar
granule neurons were prepared from 7-day-old B6 mice according to a procedure
modiﬁedfromCourtneyetal.
40Brieﬂy,thecerebellumwasmechanicallydissociated
andﬁlteredthrougha70-mmnylonmeshﬁlter(SmallParts,MiamiLakes,FL,USA).
Cells were plated onto a plastic culture plate that was pre-coated with poly-L-lysine
(30mg/ml; Sigma-Aldrich) and maintained in Dulbecco’s modiﬁed Eagle’s medium
Glutamax-I (Invitrogen, Carlsbad, CA, USA) medium containing 10% fetal bovine
serum (FBS; Invitrogen), 20mM KCl, and 100U/ml penicillin and streptomycin
(Invitrogen), and completed with N2 and B27 supplements (Invitrogen). The growth
of non-neuronal cells was inhibited by the addition of the antimitotics, uridine, and
ﬂuorodeoxyuridine(10mM;Sigma-Aldrich),for18hafterseeding.Cellswerekeptat
371C in a humidiﬁed atmosphere of 5% CO2 and 95% air.
Immunoﬂuorescence. Cells were ﬁxed for 15min with 4% formaldehyde in
phosphate-buffered saline (PBS) and then permeabilized with cold acetone.
Antibodies were then incubated with ﬁxed cells for 4h at room temperature. Cells
were washed three times with PBS followed by incubation with a secondary
antibody for 1h at room temperature. Nuclei were revealed by ProLong Gold
antifade reagent with DAPI (Invitrogen). Coverslips were inverted, mounted on
slides, and sealed with nail polish. Pictures were taken using ﬂuorescence
microscopy.
P19 cell neuronal differentiation. Mouse embryonal carcinoma P19 cells
were used in this study, and RA-induced P19 cell neuronal differentiation was
performed with a slight modiﬁcation of procedures described by Lee et al.
41 Brieﬂy,
P19cellsweremaintainedinalphaminimumessentialmedium(a-MEM;Invitrogen)
supplemented with 7.5% bovine serum (BS; Invitrogen)and 2.5% FBS at 371Ci na
humidiﬁed atmosphere (5% CO2 and 95% air). To induce differentiation, cells were
allowed to aggregate in bacterial-grade Petri dishes at a seeding density of 1 10
5
cells/ml in the presence of 1mM all-trans-RA (Sigma-Aldrich). After 4 days of
aggregation, cells were dissociated into single cells by trypsin-EDTA, and were
plated in a poly-L-lysine-coated tissue culture dish at a density of 1 10
5 cells/cm
2
in Neurobasal-A medium (Invitrogen) with a 1  B27 supplement. Cells were
allowed to attach for 24h, and then were exposed to 10mM Ara-C 24h to inhibit
proliferation of non-neuronal cells.
Reverse transcription (RT) and quantitative (q) real-time PCR
assays. Total RNA was extracted using the Trizol reagent (Invitrogen) following
the manufacturer’s recommendations. RT was performed with 1.5mg of total RNA
using M-MLV reverse transcriptase (Invitrogen). A real-time qPCR was performed
using the SYBR advantage qPCR premix (Invitrogen). The PCRs were then
performedusingthefollowingconditionsfor40cycles:951Cfor15s,601Cfor15s,
and 721C for 20s. Sequences of the primers used are listed in Supplementary
Table 1. Real-time ﬂuorescence monitoring and a melting-curve analysis were
performed with LightCycler according to the manufacturer’s recommendations
(Roche Molecular Diagnostics, Lewes, East Sussex, UK). Negative controls
containing no cDNA template were included in each experiment. A melting curve
was created at the end of the PCR cycle to conﬁrm that a single product had been
ampliﬁed. Data were analyzed by LightCycler software vers. 3.5 (Roche Molecular
Diagnostics) to determine the threshold cycle (Cp) above the background for each
reaction. The relative transcript amount of the target gene, calculated using standard
curves of serial cDNA dilutions, was normalized to that of b-actin of the same cDNA.
Western blot analysis. Cells were rinsed with ice-cold PBS and lysed in
radioimmunoprecipitation assay buffer (150mM NaCl, 1% NP40, 0.5%
Na-deoxycholate, 0.1% sodium dodecylsulfate, and 50mM Tris-HCl; pH 8.0) with
the addition of a protease inhibitor cocktail (Roche Molecular Diagnostics). Cell
debris was removed by centrifugation at 12000r.p.m. for 15min at 41C, and the
supernatant was utilized for a western blot analysis. Protein concentrations were
determined using the Bio-Rad dye-binding method (Bio-Rad Laboratories,
Hercules, CA, USA) with bovine serum albumin as the standard. Equal amounts
ofsamplewereseparatedby10%polyacrylamidegelelectrophoresis.Theresolved
proteins were then electroblotted onto Immobilon polyvinylidene diﬂuoride mem-
branes (Millipore, Bedford, MA, USA). Membranes were blocked with 5% nonfat
milk and then sequentially incubated with the primary and secondary antibodies.
After washing, the blots were processed for visualization using an enhanced
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Cell Death and Differentiationchemiluminescencesystem(Pierce,Rockford,IL,USA).Blotswerethenexposedto
X-ray ﬁlm to obtain the ﬂuorographic images.
Lentiviral vector production and infection. Replication-deﬁcient
lentiviruses were generated by transient transfection of shRNAs, the packaging
vector, pCMV-DR8.91 (containing the gag, pol, and rev genes), and the envelope
plasmid, pMD.G (VSV-G-expressing plasmid), in 293T cells using the Trans IT-LT1
reagent (Mirus Bio, Madison, WI, USA). The shRNAs included Znf179
shRNAs (TRCN0000040979 and TRCN0000040980), which targeted the mouse
Znf179 transcript sequences, 50-GCCGGAAGATCTGTAAGCAAA-30 (sh_2) and
50-GATACCGATCTGGGCTATCTA-30 (sh_3), p35 shRNA (TRCN0000009518),
which targeted the mouse p35 transcript sequence, 50-GACCCACACTATTT
CACACAA-30 (sh_4), and the luciferase control (pLKO.1-shLuc) plasmid constructs
were used. To monitor and track the virus titer, the puromycin resistance gene on
pLKO.1-based lentiviral vectors was replaced with EGFP. To generate p35
expression vectors, p35 and EGFP-p35 cDNA fragments were inserted into
the BamHI and KpnI sites of the sh_2 and shLuc constructs. Beginning at 36h
post-transfection, the viral supernatant was collected every 24h for
4 days. The pooled supernatant was cleared by low-speed centrifugation
followed by ﬁltering through 0.45-mm ﬁlters. Viral particles were concentrated by
ultracentrifugationat110500gfor2h.PelletswereresuspendedinPBSat1/500of
the original volume and kept at  701C. The titer of viral stocks was determined by
ﬂow cytometric analysis of EGFP expression 48h after infection. In general, viral
titers were about 3B5 10
7TU/ml. P19 cells were infected twice with the virus
(MOI¼4) before 2 days and at the days of cell aggregation in 8mg/ml polybrene.
Cell viability assay. Cell viability was determined by adding MTT (Sigma-
Aldrich) to the cell cultures at a ﬁnal concentration of 0.5mg/ml. After a 1-h
incubation at 371C, the medium was discarded, and the dark crystals formed were
dissolved in DMSO. The absorbency at 550nm was measured on a micro-enzyme-
linked immunosorbent (ELISA) reader.
DNA microarray and IPA. Total RNA was extracted using the Trizol reagent
(Invitrogen) following the manufacturer’s recommendations, and RNA integrity was
assessed using the Experion RNA StdSens Analysis Kit (Bio-Rad Laboratories).
Microarray experiments were performed using MouseWG-6 v2.0 BeadChips, and
over 48000 known genes, gene candidates, and splice variants were analyzed
(Illumina, San Diego, CA, USA) according to the instructions provided. The cDNA
and cRNA were prepared from 500ng of total RNA using Ambion’s Illumina RNA
Ampliﬁcation kit (Ambion, Austin, TX, USA) following their instructions. The cRNA
was hybridized to Illumina’s MouseWG-6 v2.0 BeadChips, which were scanned on
an Illumina BeadStation 500 . Illumina Beadstudio software was used to assess
ﬂuorescent hybridization signals. Before proceeding with the differential gene
expression analysis, quantile normalization algorithms, present in the Illumina data
analysissoftware,BeadStudio,
42wereappliedtothedata.Tointerpretthebiological
signiﬁcance of the candidate genes, the IPA software was used (Ingenuity,
Redwood, CA, USA). Speciﬁcally, the functional analysis tool identiﬁed the
physiological system development and functions and molecular and cellular
functions that were most signiﬁcant to the data set. A right-tailed Fisher’s exact test
was used to calculate a P-value, which indicated the probability that each biological
function assigned to the data set was due to chance alone.
Cell cycle analysis. Cells were trypsinized, collected by centrifugation,
resuspended, and washed in PBS before ﬁxing in 75% ethanol for 1h at room
temperature. Fixed cells were incubated with 20mg/ml propidium iodide, 10mg/ml
RNase A, and 0.1% Triton X-100 for 30min before analysis. The cell cycle was
analyzed using a BD FACS Calibur ﬂow cytometer (BD Biosciences, San Jose, CA,
USA), and the data were analyzed using WinMDI software (Joseph Trotter, Scripps
Research Insitute, La Jolla, CA, USA).
BrdU incorporation. P19 cells, which were aggregated in the presence of
1mM RA for 4 days, were dissociated and plated in a-MEM (Invitrogen)
supplemented with 7.5% BS (Invitrogen) and 2.5% FBS (Invitrogen). BrdU (Sigma-
Aldrich),at 40mM, was addedto the mediaand incubatedfor 4h before ﬁxation.An
anti-BrdU antibody (Sigma-Aldrich) was used for immunoﬂuorescence.
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